Heron Therapeutics(HRTX)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Aponvie | Aprepitant | 2022-09-16 | 2027-2035 | |
| Cinvanti | Aprepitant | 2017-11-09 | 2027-2035 | |
| Sustol | Granisetron | 2016-08-09 | 2024-2025 | |
| Zynrelef | Bupivacaine, Meloxicam | 2021-05-12 | 2025-2041 |
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use